.png)
LifeSci Continuum with Bill Schick
I'm a Fractional Chief Marketing Officer for life science companies and I help them accelerate product adoption & make marketing work.
This is LifeSci Continuum, where we explore the unbroken sequence of innovation, strategy, & growth in the life sciences industry. Join us as we explore the insights and experiences of founders, product managers, commercialization leaders, & marketing pros in the field.
Discover the strategies & tactics that have worked for them, hear about their challenges and triumphs, and gain valuable knowledge to help your company thrive.
From commercialization to full life cycle product management and marketing, learn about the latest trends in pharmaceutical, biotech, med device and healthcare marketing, product management, and branding.
From groundbreaking startups to exit-stage brands, we uncover the secrets to success in the life sciences, reflecting the ongoing evolution that defines our industry.
As a fractional CMO in the life sciences, I can help you establish, track, and optimize the right metrics and KPIs that align with your business objectives. This includes defining what success looks like for your specific stage of growth, whether it's early lead generation, nurturing prospects, or moving toward commercialization. I'll ensure that your marketing efforts are measured using data-driven insights, helping to identify opportunities, optimize campaigns, and make informed decisions to accelerate growth and ROI while minimizing wasteful efforts.
For more specialized help with growth, check out my firm, Mesh.
https://meshagency.com/
LifeSci Continuum with Bill Schick
How to Maximize Your Pitch for Angel, VC, and IPO Investors | David Iannetta
Follow Bill: https://www.linkedin.com/in/founderandcdo/
Contact Bill: https://meshagency.com/lets-connect/
Video Podcast: https://www.youtube.com/@BillSchickFCMO
Audio Podcast: https://www.buzzsprout.com/2380430
Follow Dave: https://www.linkedin.com/in/dave-iannetta/
_______________________________
Timestamps:
00:00 Intro
01:37 Telling a Story that Resonates with Angel Investors
03:23 Case Study
05:40 How to Pitch to Angel Investors
07:15 What Angel Investors Actually Care About
09:10 Building Confidence in Angel Investors
_______________________________
In this episode, I sit down again with seasoned marketing executive Dave Iannetta to explore how life science and med device companies can refine their marketing strategy based on where they stand in the fundraising journey.
We kick off by discussing angel investors—often deeply familiar with niche therapeutic areas—who demand more scientific detail and crave confidence in the path to clinical validation. Dave emphasizes that these early backers aren’t just sources of capital; they frequently bring networks and advisory expertise crucial for guiding pre-clinical or early-phase companies. As startups move toward VC or IPO stages, their narrative must evolve—focusing on broader market appeal, long-term viability, and the step-by-step milestones that validate their technology.
Throughout our conversation, we discuss how winning over different investor audiences hinges on adapting your message, demonstrating credibility through thoughtful planning, and clearly outlining your path to commercialization—even if it’s just a high-level preview in the early rounds.
Protips for our viewers:
1. Preemptive Future Staging
Pro Tip: Anticipate the Next Investor’s Questions Before You Even Land the Current Round. Seasoned founders don’t just satisfy the immediate audience; they also layer in hints of what VCs or public-market investors will want to see next—like clinical milestones or commercial frameworks. This helps you stay one step ahead, especially when angels (often experts in your space) start quizzing you on longer-term feasibility.
2. Convert Early Investors into Credibility Amplifiers
Pro Tip: Leverage Angel Backers’ Expertise and Networks to Strengthen Your VC or IPO Pitch. The most experienced entrepreneurs recognize that angel investors—many of whom are industry veterans—can serve as potent evangelists to higher-level funders. Make them feel like partners in your success by actively soliciting their input and showcasing how their technical insights informed critical decisions.
3. Craft a Layered Pitch Deck
Pro Tip: Design Multiple Versions of Your Deck, Each Calibrated to a Different Fundraising Stage. While angels crave deep scientific detail, VCs favor a clearer path to market, and IPO investors need a simplified “why invest now” narrative. Instead of one-size-fits-all materials, create layered versions that pivot on the fly. This agility signals to prospective investors that you deeply understand what they need to make a confident bet on your company.
For more specialized help with growth, check out my firm, Mesh.
https://meshagency.com/
#LifeSciences #HealthcareInnovation #ProductMarketing